Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating?
Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab.
Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.
Congenital and Acquired Abnormalities of the Corpus Callosum: A Pictorial Essay.
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Yes.]
[Prognostic factors of multiple sclerosis in children and adolescents after the first demyelinating event.]
Vitamin D deficiency and its role in neurological conditions: A review.
Vitamin D During Pregnancy and Multiple Sclerosis: An Evolving Association.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.
A New App for At-Home Cognitive Training: Description and Pilot Testing on Patients with Multiple Sclerosis.
Inequalities In Access to Treatment for Multiple Sclerosis In England Continue Despite Service Improvement Initiatives And Policy Reforms.
Assessing intracortical myelin in the living human brain using myelinated cortical thickness.
Attention-related changes in short-term cortical plasticity help to explain fatigue in multiple sclerosis.
A tissue-relaxation-dependent neighboring method for robust mapping of the myelin water fraction.
Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.
A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder.
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives.
Role of Autoantibodies in Acquired Inflammatory Demyelinating Diseases of the Central Nervous System in Children.
Determination of Brain Volumes Using Quantitative MR Imaging in Patients with Multiple Sclerosis.
Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis.
Longitudinal changes in quality of life and related psychosocial variables in australians with multiple sclerosis.
The Lin28/let-7 axis is critical for myelination in the peripheral nervous system.
Charcot-Marie-Tooth type 1C disease coexisting with progressive multiple sclerosis: a study of an overlapping syndrome.
ASP4058, a Novel Agonist for Sphingosine 1-Phosphate Receptors 1 and 5, Ameliorates Rodent Experimental Autoimmune Encephalomyelitis with a Favorable Safety Profile.
Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.
Pages
« first
‹ previous
…
591
592
593
594
595
596
597
598
599
…
next ›
last »